4 days left: How TechCrunch Founder Summit helps you make more useful connections to scale
Technologyvia TechCrunch
Quick Read
On November 4 at Boston’s SoWa Power Station, get ready for a full day packed with meaningful networking opportunities, actionable insights, and connections that could change the trajectory of your idea and startup. Register before all prices go up at the door.
On November 4 at Boston’s SoWa Power Station, get ready for a full day packed with meaningful networking opportunities, actionable insights, and connections that could change the trajectory of your idea and startup. Register before all prices go up at the door.
Flying across several time zones often causes jet lag, a feeling when the body insists it's the middle of the night while the clock says it's lunchtime. Now it turns out this nuisance is not exclusive to humans. A new Science study on Manx shearwaters, seabirds that can fly hundreds of kilometers a day over the North Atlantic, shows they jet-lag themselves during their excursions. And because these birds navigate by the Sun, that jet lag leaves a measurable mark—it skews their compass. Clockwork compass Patrick Lewin is a behavioral and sensory ecologist at the University of Oxford and lead author of the study. “Manx shearwaters are medium-sized birds, about the same size as a pigeon,” Lewin said. “They are white underneath and black on top, but they have very long wings, and they are closely related to albatross.” Manx shearwaters nest in burrows on coastal islands around the North Atlantic. Most breed around the UK and Ireland, with about half of their population living in Wales.Read full article Comments
In May 2021, the US Food and Drug Administration released a lengthy briefing document on an experimental medication for a rare autoimmune form of vasculitis that often damages the kidneys and lungs. The agency was on the fence about whether to approve the treatment, and it wanted an independent advisory committee to weigh in. Among the questions at hand: Was the drug meaningfully better than existing therapies? Participants in the study, which had been conducted by the California biotechnology company ChemoCentryx, did appear to have slightly higher rates of symptom remission after one year. But according to the FDA, it was hard to interpret the results because the study’s design had been less than optimal. Some advisory committee members expressed a similar view. The effect of the drug, said one, “is just not well verified by this study.” At the same time, many patients, and some physicians, saw in the data a potentially helpful medication, one that might lessen patients’ reliance on steroids, which are highly effective but often cause severe side effects.Read full article Comments
The Hubble Space Telescope still shines in the eyes of astronomers after 36 years in orbit, but it is not as nimble as it once was. Left alone, the observatory will plunge back into the atmosphere in the early-to-mid-2030s, closing the book on one of the most famous scientific instruments of the century. NASA last raised the orbit of Hubble in 2002, when the Space Shuttle Columbia visited the observatory for a servicing mission. The final shuttle servicing flight in 2009 did not reboost the telescope's orbit, and with the retirement of the shuttle fleet two years later, Hubble has steadily lost altitude with no way to stave off eventual destruction. The space agency released a Request For Information (RFI) on Thursday asking commercial companies for ideas on how to reboost, service, or a controlled disposal of Hubble. Responses are due November 30. Specifically, NASA is looking for information about companies' current and near-term capabilities for capturing Hubble and boosting it to an altitude of at least 373 miles (600 km), enhancing the telescope's performance, or guiding Hubble to a controlled reentry.Read full article Comments
